Please assess the completion status of the following clinical trial:

Trial Title: Molekule for Allergic Rhinitis/Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Chronic allergic rhinitis and/or conjunctivitis by history~2. History of adult asthma requiring medications now or in the past~3. Age ≥18~4. CARAT score less than 24~Exclusion Criteria:~1. Participant is \<18 years-old~2. Use of systemic corticosteroids within 14 days of study initiation~3. Treatment with biologic agents or allergen immunotherapy~4. Treatment with other immunomodulators (cyclosporine, azathioprine, hydroxychloroquine, etc)~5. Sensitive to fan sound or blue/purple light at night time

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Active air purifier arm (Type: EXPERIMENTAL): Active portable air purifier for 1 month at bedside
- Sham air purifier arm (Type: SHAM_COMPARATOR): Placebo portable air purifier for 1 month at bedside

Based on this trial design, predict the completion outcome and termination type (if applicable).